[first] professional anti-cancer academic platform liangyihui has completed strategic financing of tens of millions of yuan, covering 150000 doctors and 200000 patients

With the epidemic raging, Internet medicine is once again entrusted by the state It has played an important role in preventing and controlling the epidemic and solving the problem of insufficient medical resources in the epidemic area Arterial network also learned for the first time that liangyihui, the largest professional anti-cancer academic platform in China, has completed strategic financing of tens of millions of yuan, which is exclusively invested by aggregating capital, with Xinghan capital as the exclusive financial consultant After the completion of the financing, liangyihui will deepen cancer doctor-patient services and pharmaceutical enterprise services, continue to build an internet medical platform for cancer specialty, and strengthen the dissemination and education of science popularization for patients and the public During the novel coronavirus pneumonia epidemic, the medical doctor Union has combined more than 1000 high level oncology doctors in China to provide large-scale online answering public service activities for cancer patients who are out of the hospital because of the barrier of the disease Founded in 2014, liangyihui is an authoritative academic platform for cancer prevention and an official cooperation platform of China clinical oncology society The company maintains long-term and effective in-depth cooperation with many well-known hospitals and authorities at home and abroad, and is committed to solving the information asymmetry in the field of cancer The company starts from the professional content, provides professional content and efficient tools for tumor doctors, helps doctors improve the level of diagnosis and treatment, and provides scientific publicity, medical guidance, diagnosis and follow-up services for tumor patients In December 2019, at the conference of the top 100 medical companies in the future held by arterial network, liangyihui won the "top 100 medical companies in the future 2019 - Top 5 academic training for doctors" award, and Mr Wang Jue, founder and general manager, won the "ceotop10 innovation enterprise of the year" award It is understood that up to now, liangyihui has completed three rounds of financing In October 2015, the company completed a round of financing of 10 million yuan invested exclusively by Junlian capital; in December 2018, the company completed a round of financing of 10 million yuan invested by Danlu capital Wang Jue, founder and general manager of liangyihui, said: "cooperation with converged capital can provide us with strong support in better conducting science popularization and services for patients and the public." Focusing on the vertical field of cancer, serving cancer doctors and patients, and helping pharmaceutical companies to promote the marketing and upgrading of cancer are the most common causes of death for urban and rural residents in China Nearly one sixth of deaths in the world are caused by cancer The report published by the American Cancer Society's official journal clinicians cancer shows that cancer incidence rate and mortality rate in China ranks first in the world Chinese accounts for 21 of every 100 new cancer patients worldwide Wang Jue said that tumor diseases consume more than 11% of China's medical resources, and the scale of China's tumor medicine market has exceeded 300 billion US dollars At the same time, Wang Jue also noted that due to the asymmetric information, there are many disorders in the diagnosis and treatment of tumors "This field needs a professional platform to provide efficient tools for oncologists and provide popular science education services for patients." Liangyihui focuses on the field of tumor and serves doctors, patients and enterprises Its products include tumor doctor app, tumor information, patient guide and global consultation center, covering 150000 doctors and 200000 patients In terms of improving the diagnosis and treatment level of doctors, a large number of doctors from the top three hospitals and cancer specialized hospitals are gathered on the platform of good medicine pool to empower doctors through professional academic information, and help doctors build brands and manage patients The platform has more than 50000 professional contents, which have formed a knowledge system and can be close to doctors' clinical work and help them solve practical problems According to Wang Jue, liangyihui's doctor platform has a total annual reading capacity of more than 20 million people, with an average person spending more than half an hour on the platform every week In addition, there are more than 1000 live academic conferences, hospital rounds and hospital training on the platform every year "For grassroots doctors, there are very few opportunities to participate in the internal rounds and training of top hospitals, and good doctors pool provides them with opportunities for further study." At present, doctors can watch the live internal rounds of Tumor Hospital of Sun Yat sen University, Tumor Hospital of Medical College and Tianjin tumor hospital on the platform, and can watch the internal training of Fudan tumor hospital In terms of patient education, liangyihui has the patient education content covering the most kinds of tumor at present It provides professional video and text content guidance for patients to seek medical advice, carry out science education, and rely on its own expert resources to do science popularization, consultation, lectures, guidance and other work for tumor patients on the platform In the aspect of enterprise cooperation, through professional academic content, a large number of active tumor doctors have gathered in the excellent doctors pool, which has become an important platform for tumor drug marketing Compared with the traditional medical marketing methods such as offline academic conferences, medical representatives' visits, etc., marketing through the platform of liangyihui has a wider range, stronger timeliness, higher efficiency and lower marketing cost "In recent two years, the sales volume of new anti-tumor drugs on the market has grown rapidly, and online marketing channels have played an important role." Wang Jue said In recent years, many new changes have taken place in the global tumor market Tumor diagnosis and treatment mode has entered the era of precision medicine from evidence-based medicine, the speed of new drug development has been greatly accelerated, and the new drugs have better efficacy than the old ones "The field of cancer is in constant development and change Tumor doctors and patients need to update their knowledge and ideas in time What good doctors do has great social significance " Wang Jue said As a professional academic platform in tumor vertical field, liangyihui has been in the leading position in the industry "It is a long and persistent process to improve the diagnosis and treatment level of tumor doctors and patients' understanding of tumor." Wang Jue said so Next, liangyihui will continue to deepen its services to doctors, patients and enterprises "In addition, China's pharmaceutical environment is undergoing dramatic changes We hope to use our own strength to make the reform more smooth." Investors: we are a private equity capital management institution with Jiangsu Radio and television as the main investor and focusing on cultural creativity, technological innovation and other industrial fields At present, it manages multiple funds "Under the guidance of healthy China's policies, health and Internet health have great potential for development We have been focusing on the field of Internet health care in the near future, especially on specialized and vertical enterprises," said Lu Jingting, chief investment officer of aggregator capital "Liangyihui has covered a large number of accurate audiences in the tumor vertical field We are optimistic about the value of his media information and the future development space of online medical field The greater the value of information, the higher the user's trust, and the greater the user's value In the future, we also hope that liangyihui can extend its media value, increase its media access, expand its publicity and distribution path, strengthen users' trust in the brand, and explore a feasible business path in the field of online medicine, so as to better provide services for patients, doctors and hospitals " After the completion of this financing, aggregated capital will discuss and implement more business cooperation with liangyihui Penicillin